Advisers to RFK Jr drop the plan to end federal guidance amid Republican worries about the political impact ...
In one episode recorded over Zoom, a MAHA supporter, deeply frustrated with the government’s response during Covid, looked into the screen at a recently resigned Centers for Disease Control and ...
The Federal Court of Appeal has upheld the rejection of employment insurance (EI) benefits requested by an employee who ...
Moderna CEO Stéphane Bancel’s total compensation remained remarkably stable last year at $19.9 million, even as the vaccines company navigated a “challenging regulatory and business environment.” ...
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
A BC employee who raised concerns about a COVID conspiracy video in his workplace group chat resigned citing racial ...
Dr Vinay Prasad, who leads the FDA division that oversees vaccines and complex medical treatments, is leaving the agency at the end of April.
Few corporate cautionary tales are as vivid as the rise and fall of Moderna Inc. During the pandemic, the company’s mRNA vaccine was approved and distributed in record time, saving millions of lives ...
Federal government trying one last time to validate its invocation of the Emergencies Act to deal with the 2022 Freedom ...
The relaunch aims to move Aarogya Setu away from being a covid-era tracking tool and position it as a supplement to India’s digital health infrastructure. It involves a complete overhaul of the app’s ...
Immunis Inc. has struck a licensing deal with Japanese material manufacturer Toray Industries Inc. to develop a potential treatment for Parkinson’s-associated involuntary movement.
Researchers at Stanford University have developed a nasal spray that offers months of protection against Covid-19 and hospital germs in laboratory tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results